Introduction of Non-Animal Capsules into Japan
HIGH POINT, NC — Dr. Roger Gordon, president and CEO of Banner Pharmacaps (Banner) announced the establishment of an exclusive technical and commercial collaboration between Banner and Rohto Pharmaceuticals of Osaka, Japan (Rohto) to provide nutritional and pharmaceutical products for the Japanese market. Under the arrangement, Banner will exclusively supply certain soft gelatin capsules to Rohto in Japan. The companies intend to discuss forming a joint venture or other strategic alliance in the future to produce and market products using Banner’s proprietary technologies within Japan.
Banner’s EcoCaps™ Non-Animal Softgel capsules, made with unique and patent-pending technologies, will be introduced to the Japanese market under this new arrangement. The availability of Banner’s EcoCaps™ capsules will allow Rohto to meet the growing regional demand for bovine-free food, drugs, and nutritional supplements.
“Banner’s extensive experience in soft capsule development and manufacturing will provide Rohto the immediate advantage of being able to market a number of non-animal softgel products within Japan,” says Dr. Gordon. “They will also have the advantage of Banner’s technological leadership that focuses on the development of new drug delivery forms and the development of proprietary consumer health care products. We are very pleased to be partnering with Rohto, which is a very strong market leader with such well known brands in the US such as Mentholatum®, and we look forward to this partnership growing in the future.”
About Banner Pharmacaps Inc.
Banner is a global company that researches, develops, and manufactures drug delivery technologies and proprietary healthcare products. With state-of-the-art, FDA-approved manufacturing facilities and significant investment in research and development, Banner provides innovative oral delivery solutions and unique products to the health care industry worldwide. A wholly owned subsidiary of Sobel N.V., Banner has operations in the United States, Canada, Europe, Latin America and Asia-Pacific. Sobel is headquartered in Best, The Netherlands, and is part of the non-listed Dutch multinational Best Agrifund with revenue of about EURO 6.0 Billion (USD 7.2 Billion) and more than 15,000 employees.
About Rohto Pharmaceutical Company
Rohto Pharmaceutical Company, LTD is one of Japan’s top health care companies with a well-balanced product portfolio in oral medicines, eye care, skin care, supplements and other pharmaceutical products. The company has experienced recent growth in overseas sales, and has a growing presence within a number of major retail drug chains in the U.S.
With Research & Development laboratories located in Philadelphia, PA and global operating facilities, Rohto distributes more than 150 products. Rohto markets a number of top selling products using innovative drug delivery technologies throughout Japan, and holds dominant market share positions in Allergy, Eye Care, Lip Care, Sunscreen, and Dry Skin - Dermatology categories, among others.